Work

Phase II Study of MGI-114 Administered Intravenously for 5 Days Every 28 Days to Patients With Metastatic Colorectal Cancer

Year: 2003

Type: article

Study design: Clinical Trial

Source: American Journal of Clinical Oncology

DOI: 10.1097/00000421-200304000-00006

Authors: Sunita Dwivedy Nasta, Paulo M. Hoff, Christopher S. George, Marcus Neubauer, Steven C. Cohen, James Abbruzzese, Rodger Winn, Richard M. Pazdur

Institutions: Main Line Health, United States Food and Drug Administration, The University of Texas MD Anderson Cancer Center, Columbus Community Clinical Oncology Program

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2322776183

FWCI: 0.692

Cites: 10

Cited by: 7

Related to: 10